Table 3.
Excess mortality |
Relative mortality |
|||||||
---|---|---|---|---|---|---|---|---|
EMR | 95% CI | P value | LR testa | RMR | 95% CI | Pvalue | LR testa | |
Sex | ||||||||
Male | 1 | 1.1 | 1 | 158.2 | ||||
Female | 1.05 | 0.96–1.15 | 0.29 | (0.29) | 1.65 | 1.52–1.78 | <0.001 | (<0.001) |
Age (years) | ||||||||
<80 | 1 | 78.5 | 1 | 162.9 | ||||
≥80 | 1.54 | 1.41–1.69 | <0.001 | (<0.001) | 0.61 | 0.56–0.66 | <0.001 | (<0.001) |
First modality of dialysis | ||||||||
Hemodialysis | 1 | 4.2 | 1 | 2.9 | ||||
Peritoneal dialysis | 1.15 | 1.01–1.30 | 0.036 | (0.04) | 1.10 | 0.99–1.22 | 0.08 | (0.1) |
Primary nephropathy | ||||||||
Hypertensive/vascular | 1 | 114.9 | 1 | 138.6 | ||||
Diabetes | 1.29 | 1.14–1.45 | <0.001 | (<0.001) | 1.36 | 1.23–1.50 | <0.001 | (<0.001) |
Glomerulonephritis | 0.92 | 0.75–1.13 | 0.42 | 0.99 | 0.84–1.16 | 0.88 | ||
Interstitial nephritis/pyelonephritis | 0.97 | 0.80–1.19 | 0.78 | 1.05 | 0.90–1.23 | 0.54 | ||
Tumoral/myeloma/amyloid | 2.75 | 2.30–3.28 | <0.001 | 2.60 | 2.21–3.05 | <0.001 | ||
Miscellaneous/unknown/missing | 1.09 | 0.96–1.24 | 0.16 | 1.06 | 0.96–1.17 | 0.24 |
Note:
Chi-squared test (P value) provided.
Abbreviations: CI, confidence interval; EMR, excess mortality ratio; LR, log-likelihood ratio; RMR, relative mortality ratio.